Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
injection
|
| gptkbp:approvedBy |
gptkb:U.S._Food_and_Drug_Administration
2010 |
| gptkbp:ATCCode |
gptkb:J07AH08
|
| gptkbp:contains |
gptkb:CRM197_protein
meningococcal oligosaccharide antigens |
| https://www.w3.org/2000/01/rdf-schema#label |
Menveo
|
| gptkbp:indication |
individuals 2 months to 55 years of age
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:GSK
gptkb:Novartis |
| gptkbp:protectedBy |
gptkb:Neisseria_meningitidis_serogroup_A
gptkb:Neisseria_meningitidis_serogroup_C gptkb:Neisseria_meningitidis_serogroup_W-135 gptkb:Neisseria_meningitidis_serogroup_Y |
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
fatigue headache pain at injection site redness irritability swelling |
| gptkbp:storage |
2°C to 8°C
|
| gptkbp:type |
vaccine
|
| gptkbp:usedFor |
prevention of meningococcal disease
|
| gptkbp:WHOPrequalified |
yes
|
| gptkbp:bfsParent |
gptkb:Novartis_Vaccines_and_Diagnostics
|
| gptkbp:bfsLayer |
6
|